SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitor–Mediated Blunting of Blood Volume Redistribution: A Candidate Mechanism for Attenuating Cardiac Filling Pressures and Exercise Intolerance in Heart Failure—How Do the Data Stack up?
Wayne L. Miller
Correspondence to: Wayne L. Miller, MD, PhD, Department of Cardiovascular Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905. Email
E-mail Address: [email protected]
https://orcid.org/0000-0002-0863-9509
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.